Figure 6
From: The in vivo properties of STX243: a potent angiogenesis inhibitor in breast cancer
Concentration of STX243 in rat plasma after a single oral administration (A) or a single intravenous injection of STX243 (B). Animals were dosed with either 10 or 40 mg kg−1 STX243. Plasma samples were evaluated according to the HPLC analysis procedure described in the Materials and Methods section. Data represent mean±s.d., n=3.
